Houston C diff & Microbiome Conference
Houston C diff & Microbiome Conference
Thursday, May 16, 2024
Bioscience Reseach Collaborative, Rice University, 6500 Main St., Houston
Registration & Abstract Submission CLOSED
The Houston C diff. & Microbiome Conference aims to bring together research trainees and researchers from infectious diseases laboratories in the Texas Medical Center, Houston and the surrounding area for a lively forum to discuss the latest findings and cutting-edge developments from their labs as well as foster new and exciting collaborations.
A major focus of the conference is to provide an outlet for trainees and junior scientists to share their work, discuss their data with leading scientists, and inspire the next generation of Clostridiodes difficile/ microbiome researchers.
In addition to two keynote speakers, abstracts are invited and competitively selected for oral presentation. Remaining abstracts will be presented during the course of one or more poster sessions, allowing every participant a chance to highlight their research. Attendees are encouraged to submit abstracts on their most recent or as-yet-unpublished work.
Sponsored by Acurx Pharmaceuticals
Tentative Schedule
8:00-9:00 am | Check-in |
8:50-9:00 am | Welcome Remarks: Kevin Garey, UHCOP |
9:00-9:45 am | Keynote 1 - Tor Savidge, Convener Speaker: Blake Hanson, UTHSC Title: TBD |
10:00-11:00 am | Abstract Presentations 1-4, Conveners: Rob Britton and Sara Dann |
10:00 am | 1: Taryn Eubank, UHCOP Title: "Efficacy and safety of ibezapolstat compared with vancomycin for the treatment of Clostridioides difficile infection: a phase 2, randomized, double-blind study" |
10:15 am | 2: Francisca Cid-Rojas, TAMU Title: "Characterization of a hypersporulating Clostridioides difficile strain" |
10:30 am | 3: Merilyn A. Beebe, TAMU Title: "Phenotypic characterization of C. difficile ribotypes" |
10:45 am | 4: Travis J. Carlson, UTSA Title: "The Majority of Adults with Discordant Clostridioides difficile Testing Results are Treated for C. difficile Infection Despite Alternative Explanations for Their Diarrhea" |
11:00 am-12:00 pm | Abstract Presentations 5-8, Conveners: Daniel Paredes-Sabja and Margaret Conner |
11:00 am | 5: Marjorie Pizarro-Guajardo, TAMU Title: "C. difficile interaction with the complement system: Implications in pathogenesis" |
11:15 am | 6: Javier Sanchez-Peralta, TAMU Title: "Determining the role of cysteine rich proteins CDEC in exosporium assembly and morphogenesis of C. difficile spores" |
11:30 am | 7: Osiris K. López-García, TAMU Title: "Bioluminescence-spore tagging approach to track sporulation dynamics and biodistribution of Clostridioides difficile spores in the gastrointestinal tract" |
11:45 am | 8: Zhilei Chen, TAMU HSC Title: "Engineer DARPin-based oral protein therapeutics for treating C. difficile infection" |
12:00-1:15 pm | Lunch & Poster Presentations |
1:15-2:00 pm | Keynote 2 - Cesar Arias, Convener Speaker: Xinyun (Sherry) Cao, UTSW Title: "Towards novel antibiotics discovery: transcription and regulation of C. difficile" |
2:00-3:00 pm | Abstract Presentations 9-12, Conveners: Travis J. Carlson and Jinhee Jo |
2:00 pm | 9: Henok A. Tegegne, BCOM Title: "Hi-C Metagenomic Characterization of the Host-Antimicrobial Resistome in Clostridioides difficile Infection" |
2:15 pm | 10: Chetna Dureja, TAMU HSC Institute Title: "Evaluation of De Novo Fatty Acid Biosynthesis as a Narrow-Spectrum Approach for Clostridioides difficile infection" |
2:30 pm | 11: Ann M. McKelvey, TAMU HSC Institute Title: "Investigating Fitness Costs of Fidaxomicin-Resistant Clostridioides difficile" |
2:45 pm | 12: Hossaena Ayele, UTSPH Title: "Understanding Gut Microenvironment Perturbation with Moxifloxacin Therapy: Implications for Clostridioides difficile Risk" |
3:00-4:00 pm | Abstract Presentations 13-16, Conveners: Eugenie Basseres and Zhilei Chen |
3:00 pm | 13: Katherine J. Wozniak, BCOM Title: "Understanding Clostridioides difficile RT023 xylitol utilization" |
3:15 pm | 14: Andie deTranaltes, Houston Methodist Hospital Title: "Characterization of Clostridiodes difficile Colonization in Critically Ill Patients" |
3:30 pm | 15: Joshua N. Brehm, TAMU Title: "Investigating the role of Clostridioides difficile small, acid-soluble spore proteins during spore outgrowth" |
3:45 pm | 16: Morgan S. Osborne, TAMU Title: "The impact of YabG mutations on C. difficile spore germination and processing of spore substrates" |
4:00 pm | Closing Remarks & Directions to Happy Hour - Julian Hurdle |
4:30 pm-sunset | Happy Hour - Little Woodrow's, Rice Village, 5611 Morningside Dr. |
Organizing Committee
Robert Britton, Ph.D., Professor, Baylor College of Medicine
Kevin Garey, Pharm.D., M.S., Professor, University of Houston
Julian Hurdle, Ph.D., Professor, Texas A&M University Institute of Biosciences and Technology
Joseph Sorg, Ph.D., Professor, Texas A&M University
Contact
Questions? Please contact Kevin Garey at kgarey@central.uh.edu or 832-842-8386.